Bevicra Injection
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Bevacizumab (400mg)
Overview Bevicra Injection
Bevicra Injection combats cancer by inhibiting tumor growth. It's indicated for colorectal, non-small cell lung, kidney, brain, ovarian, and cervical cancers. Its mechanism involves suppressing the formation of tumor-supplying blood vessels. Highly effective, Bevicra Injection is often a first-line treatment in combination therapy, administered intravenously via infusion—either directly into a vein or through a surgically implanted port. Dosage and treatment length are determined by your physician, who will monitor for infusion reactions like hypertension and respiratory distress. Continued use depends on disease control and manageable side effects, as assessed by your doctor. Regular monitoring of blood pressure and urinary protein levels may be recommended. Common side effects include rectal bleeding, altered taste, and headaches. Pre-surgical notification is crucial due to Bevicra's potential to impair wound healing and increase bleeding risk; report any unusual bleeding promptly. Disclose pregnancy, pregnancy planning, or breastfeeding to your doctor. Inform your healthcare provider of all other medications you're taking, as interactions are possible.
Primary Ingredients of Bevicra Injection
No text was provided to rewrite.
Uses of Bevicra Injection
Colorectal, ovarian, cervical, and kidney cancers; brain tumors; non-small cell lung carcinoma.
Major Benefits of Bevicra Injection:
This medication will be administered by your physician or their qualified associate; self-medication is strictly prohibited.
Common Side effects of Bevicra Injection:
- Exfoliative dermatitis
- High blood pressure
- Nosebleeds
- Protein in urine
- Decreased appetite
- Electrolyte imbalance
- Peripheral sensory neuropathy
- Breathlessness
- Thromboembolism
- Wound healing complications
- Ovarian failure
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Mucosal inflammation
- Abscess
- Cellulitis
- Hypersensitivity
- Rectovaginal fistula
How to use Bevicra Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Bevicra Injection works:
Bevicra Injection combats tumor growth by inhibiting angiogenesis. Its mechanism involves VEGF blockade, thereby preventing the development of new blood vessels that supply tumors with essential oxygen and nutrients.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Bevicra Injection may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Bevicra Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Bevicra Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Administering Bevicra Injection may induce adverse reactions that can compromise driving capabilities. Reports indicate drowsiness and loss of consciousness as potential side effects of Bevicra Injection, thereby impacting safe driving.
KidneySAFE IF PRESCRIBED
The use of Bevicra Injection in individuals with kidney disease appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Bevicra Injection in patients with liver disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Bevicra Injection :
Omitting a scheduled Bevicra Injection warrants immediate physician consultation.
Facts to Know About Bevicra Injection
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | VEGF inhibitor |
3,018 People bought this recently